Detalles de la búsqueda
1.
Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors.
Br J Cancer
; 125(2): 229-239, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33828255
2.
Temporary Organ Displacement to Escalate Radiation Dose to Retroperitoneal Tumors and Decrease Toxicity to Organs at Risk.
J Vasc Interv Radiol
; 31(10): 1578-1586, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861570
3.
Pathological characteristics of spine metastases treated with high-dose single-fraction stereotactic radiosurgery.
Neurosurg Focus
; 42(1): E7, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28041326
4.
The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Neurosurg Focus
; 42(1): E6, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28041329
5.
Results of photon radiotherapy for unresectable salivary gland tumors: is neutron radiotherapy's local control superior?
Radiol Oncol
; 48(1): 56-61, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24587780
6.
Digital twins for health: a scoping review.
NPJ Digit Med
; 7(1): 77, 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519626
7.
Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.
JCO Precis Oncol
; 7: e2200518, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36787508
8.
Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program.
J Cancer Res Clin Oncol
; 149(1): 69-77, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36117189
9.
Identification of Key Elements in Prostate Cancer for Ontology Building via a Multidisciplinary Consensus Agreement.
Cancers (Basel)
; 15(12)2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370731
10.
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
Pract Radiat Oncol
; 13(2): e149-e165, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36522277
11.
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study.
Cancer Med
; 12(2): 1869-1877, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35796421
12.
Consensus Quality Measures and Dose Constraints for Breast Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
Pract Radiat Oncol
; 13(3): 217-230, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36115498
13.
Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel.
Pract Radiat Oncol
; 13(5): 413-428, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37075838
14.
Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
Pract Radiat Oncol
; 12(5): 409-423, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35667551
15.
Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative.
Pract Radiat Oncol
; 12(6): 468-474, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690354
16.
Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
JAMA Netw Open
; 5(1): e2144027, 2022 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35040965
17.
Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel.
Pract Radiat Oncol
; 12(5): 424-436, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35907764
18.
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease.
J Natl Cancer Inst
; 114(12): 1656-1664, 2022 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36053178
19.
Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
Int J Gynecol Cancer
; 21(6): 1091-6, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21738045
20.
Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images.
J Immunother Cancer
; 9(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34135101